Eagle Competitors

Stocks . Korea . 
Stock . Eagle Veterinary Technology
044960 Stock  KRW 4,940  60.00  1.20%   
Eagle Veterinary Tec competes with Hwangkum Steel, Nable Communications, Iljin Display, Kakao Games, and A Tech; as well as few others. The company operates under Healthcare sector and is part of Pharmaceuticals industry. Analyzing Eagle Veterinary competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Eagle Veterinary to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Eagle Veterinary Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Eagle Veterinary competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
4,9384,9404,942
Details
Intrinsic
Valuation
LowRealHigh
4,9374,9394,940
Details
Naive
Forecast
LowNextHigh
5,0375,0395,041
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4,6674,9615,255
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Eagle Veterinary. Your research has to be compared to or analyzed against Eagle Veterinary's peers to derive any actionable benefits. When done correctly, Eagle Veterinary's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Eagle Veterinary Tec.

Eagle Veterinary Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Eagle Veterinary and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Eagle and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Eagle Veterinary Tec does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
071670
+ 0.92
032560
071670
+ 0.88
020760
020760
+ 0.83
032560
293490
+ 0.76
032560
071670
+ 0.67
293490
293490
+ 0.54
020760
  
High negative correlations   
171120
- 0.86
020760
171120
- 0.77
071670
171120
- 0.63
032560
171120
- 0.34
293490
032820
- 0.31
020760
032820
- 0.25
071670

Risk-Adjusted Indicators

There is a big difference between Eagle Stock performing well and Eagle Veterinary Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eagle Veterinary's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Eagle Veterinary Competitive Analysis

The better you understand Eagle Veterinary competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Eagle Veterinary's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Eagle Veterinary's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
044960 032560 153460 020760 293490 071670 171120 032820 010280
 1.20 
 4,940 
Eagle
 0.98 
 5,170 
Hwangkum
 2.50 
 6,570 
Nable
 0.35 
 849.00 
Iljin
 2.33 
 17,980 
Kakao
 0.84 
 5,900 
071670
 0.40 
 2,490 
Lion
 0.65 
 2,290 
Woori
 0.16 
 625.00 
Ssangyong
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Modest
Weak
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Below Average
Below Average
Low
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
1.97
N/A
3.64
N/A
7.8
0.96
3.12
0.75
N/A
Net Asset
52.6 B
N/A
31.14 B
117.46 B
4.31 T
199.72 B
140.81 B
148.1 B
N/A
Profit Margin
0.12
N/A
-0.0697
-0.14
0.18
0.0185
0.0546
-0.0613
N/A
EBITDA
6.5 B
N/A
(1.28 B)
(32.38 B)
92.03 B
13.19 B
19.21 B
3.44 B
N/A
Operating Margin
0.13
N/A
-0.0944
-0.0749
0.13
0.0185
0.11
-0.0145
N/A
Current Valuation
104.56 B
N/A
22.72 B
114.39 B
5.88 T
221.85 B
157.8 B
359.4 B
N/A
Price To Book
N/A
N/A
N/A
2.07
N/A
N/A
N/A
N/A
N/A
Retained Earnings
8.1 B
N/A
10.71 B
N/A
N/A
51.53 B
N/A
(36.03 B)
N/A
Current Asset
15.41 B
N/A
17.61 B
N/A
N/A
93.71 B
N/A
25.62 B
N/A
Beta
0.98
N/A
0.31
1.83
N/A
1.32
0.7
0.46
N/A
Number Of Employees
11
N/A
6
113
3
349
2
109
N/A
Shares Outstanding
12.64 M
N/A
6.53 M
51.45 M
N/A
10 M
15.07 M
95.63 M
N/A
Cash Flow From Operations
6.13 B
N/A
3.02 B
(25.54 B)
227.79 B
12.63 B
2.17 B
8.83 B
N/A
Annual Yield
0.0028
N/A
N/A
0.0166
N/A
N/A
0.0211
N/A
N/A
Total Debt
3.44 B
N/A
11.51 M
18.45 B
612.76 B
5.66 B
478.5 M
11.24 B
N/A
Return On Equity
6.09
N/A
11.36
-0.56
30.17
5.85
8.94
11.16
N/A
Z Score
12.6
N/A
N/A
1.8
3.6
12.4
N/A
7.2
N/A
Return On Asset
0.0633
N/A
-0.0453
-0.0449
0.0342
0.0158
0.0665
-0.0037
N/A
Book Value Per Share
N/A
N/A
4769.27
N/A
N/A
N/A
N/A
N/A
N/A
Current Liabilities
8.27 B
N/A
3.93 B
N/A
N/A
107.36 B
N/A
30.02 B
N/A
Total Asset
52.6 B
N/A
31.14 B
117.46 B
4.31 T
199.72 B
140.81 B
148.1 B
N/A
Debt To Equity
0.36
N/A
N/A
N/A
0.54
73.7
8.9
153.7
N/A
Target Price
N/A
N/A
N/A
7500.0
53000.0
27000.0
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
50.0
N/A
N/A
300.0
N/A
N/A
Shares Owned By Institutions
0.17
N/A
N/A
0.23
2.13
0.5
3.3
0.66
N/A
Market Capitalization
73.07 B
N/A
51.26 B
64.57 B
3.87 T
109.7 B
107.17 B
135.79 B
N/A
Price To Earning
67.27
N/A
54.76
N/A
N/A
163.58
N/A
N/A
N/A
Price To Sales
1.73
N/A
2.51
0.55
N/A
0.36
0.94
2.82
N/A
Net Income
3.64 B
N/A
2.74 B
(43.67 B)
722.07 B
5.59 B
8.52 B
3.58 B
N/A
Earnings Per Share
N/A
N/A
N/A
N/A
326.52
N/A
N/A
N/A
N/A
Shares Owned By Insiders
38.47
N/A
66.92
43.18
61.4
49.65
67.78
7.83
N/A
Revenue
40.44 B
N/A
16.26 B
101.44 B
1.01 T
259.94 B
150.42 B
52.14 B
N/A
Working Capital
7.13 B
N/A
13.68 B
N/A
N/A
(13.65 B)
N/A
(4.4 B)
N/A
Cash And Equivalents
2.31 B
N/A
3.63 B
N/A
808.68 B
736.26 M
22.84 B
27.94 B
N/A
Cash Per Share
144.82
N/A
N/A
N/A
N/A
222.34
N/A
158.44
N/A
Gross Profit
12.08 B
N/A
11.85 B
(24.27 B)
495.52 B
22.57 B
28.94 B
14.28 B
N/A
Day Typical Price
4955.0
5133.33
6530.0
855.33
17836.67
5923.33
2491.67
2306.67
624.33
Accumulation Distribution
580.76
345.95
61.97
643.37
5728.51
137.42
1386.86
69364.86
488.13
Market Facilitation Index
0.0019
0.0161
0.14
6.0E-4
0.0029
0.0099
0.0021
0.0
5.0E-4
Daily Balance Of Power
(0.80)
0.2941
0.6667
(0.16)
0.7455
(0.56)
(0.12)
(0.25)
0.0833
Period Momentum Indicator
(60.00)
50.0
160.0
(3.00)
410.0
(50.00)
(10.00)
(15.00)
1.0
Rate Of Daily Change
0.99
1.01
1.02
1.0
1.02
0.99
1.0
0.99
1.0
Day Median Price
4962.5
5115.0
6510.0
858.5
17765.0
5935.0
2492.5
2315.0
624.0
Price Action Indicator
(52.50)
80.0
140.0
(11.00)
420.0
(60.00)
(7.50)
(32.50)
1.5
Relative Strength Index
49.33
45.97
54.28
31.9
55.44
41.59
51.65
51.51
56.23
Coefficient Of Variation
(4,481)
(709.04)
(1,957)
(312.77)
2638.87
(872.81)
1200.23
1844.14
1988.85
Mean Deviation
1.15
0.8922
0.7614
0.8228
2.04
1.34
1.76
2.88
0.8526
Jensen Alpha
(0.06)
(0.16)
(0.07)
(0.34)
0.0699
(0.27)
0.1837
0.1572
0.0428
Total Risk Alpha
(0.27)
(0.36)
(0.27)
(0.53)
(0.30)
(0.57)
(0.19)
(0.39)
(0.12)
Sortino Ratio
N/A
N/A
N/A
N/A
(0.01)
N/A
0.0397
0.0288
(0.06)
Downside Variance
N/A
N/A
N/A
N/A
5.81
N/A
6.63
8.94
1.17
Standard Deviation
1.52
1.19
1.29
1.1
2.54
2.12
2.73
3.9
1.1
Kurtosis
0.8258
0.6275
5.49
0.7314
0.0893
5.09
2.88
1.72
1.16
Potential Upside
2.66
2.02
2.34
1.56
4.06
2.57
4.3
7.38
1.64
Treynor Ratio
(0.25)
1.42
1.1
2.13
0.6146
(2.28)
0.7399
0.5237
2.14
Maximum Drawdown
7.75
5.46
5.78
5.6
12.61
11.38
16.45
20.5
5.21
Variance
2.31
1.4
1.67
1.21
6.43
4.5
7.47
15.23
1.21
Market Risk Adjusted Performance
(0.24)
1.43
1.11
2.14
0.6246
(2.27)
0.7499
0.5337
2.15
Risk Adjusted Performance
(0.01)
(0.10)
(0.04)
(0.24)
0.036
(0.08)
0.071
0.0496
0.0415
Skewness
0.0957
0.0603
(0.63)
0.2656
0.2648
0.8853
0.5004
1.06
0.4087
Semi Deviation
N/A
N/A
N/A
N/A
2.25
N/A
2.16
2.79
0.9358
Information Ratio
(0.10)
(0.25)
(0.15)
(0.43)
(0.01)
(0.17)
0.0374
0.0221
(0.06)
Value At Risk
(2.39)
(2.12)
(1.85)
(2.05)
(3.67)
(3.66)
(3.79)
(4.82)
(1.32)
Expected Short fall
N/A
N/A
N/A
N/A
(2.26)
N/A
(2.31)
(3.87)
(0.99)
Downside Deviation
N/A
N/A
N/A
N/A
2.41
N/A
2.57
2.99
1.08
Semi Variance
N/A
N/A
N/A
N/A
5.05
N/A
4.65
7.81
0.8757

Eagle Veterinary Competition Performance Charts

Five steps to successful analysis of Eagle Veterinary Competition

Eagle Veterinary's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Eagle Veterinary Tec in relation to its competition. Eagle Veterinary's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Eagle Veterinary in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Eagle Veterinary's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Eagle Veterinary Tec, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Eagle Veterinary position

In addition to having Eagle Veterinary in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Long Short Funds Thematic Idea Now

Long Short Funds
Long Short Funds Theme
Funds or Etfs that are designed to hedge away market risk by investing in combination of bonds, stocks, derivative instruments as well as short positions to maximize returns irrespective of market conditions. The Long Short Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long Short Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Eagle Stock

Eagle Veterinary financial ratios help investors to determine whether Eagle Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eagle with respect to the benefits of owning Eagle Veterinary security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY